Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 21

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 21
---
8, but there is a grandfather rule for compensation paid pursuant to a written, binding contract that was in effect on November 2, 2017, which was not modified in any material respect on or after that date. Awards granted under the Second Amended and Restated 2021 Plan to our covered employees, whether performance -basedor otherwise, will be subject to the $1.0 million annual deduction limitation 14 under Section 162(m). The Board of Directors or the Compensation Committee, as applicable, intends to consider the potential impact of Section 162(m) on compensation decisions, but reserves the right to grant awards under the Second Amended and Restated 2021 Plan that may not be deductible because of Section 162(m), as the Board of Directors or the Committee in the exercise of its business judgment determines appropriate to meet our compensation objectives. New Plan Benefits.SEC rules require us to disclose any amounts that we currently are able to determine will be allocated to our named executive officers, directors and other employees following approval of the Second Amended and Restated 2021 Plan. The aggregate benefits or amounts, including shares or options to be received by or allocated to certain executive officers, directors or other employees are not known with specificity at this time. All benefits under the Second Amended and Restated 2021 Plan shall be subject to approval by the stockholders. Eligible Persons Under the Second Amended and Restated 2021 Plan.As of the Record Date, there were approximately 22 employees and 4 non -executivedirectors eligible for Awards under the Second Amended and Restated 2021 Plan. The number of other service providers potentially eligible to participate in the Second Amended and Restated 2021 Plan is not currently determinable. Federal Income Tax Information Regarding the Second Amended and Restated 2021 Plan. The following is a brief summary of the principal federal income tax consequences of awards under the Second Amended and Restated 2021 Plan to U.S. taxpayers and the Company based on applicable provisions of the Internal Revenue Code and Treasury Regulations now in effect. The following discussion assumes that the fair market value of our common stock on the date of exercise is greater than the per share exercise price. Nonstatutory Stock Options.No taxable income is reportable when a nonstatutory stock option with an exercise price equal to the fair market value of the underlying stock on the date of grant is granted to a participant. Upon exercise, the participant will recognize ordinary income in an amount equal to